Breast Cancer Research and Treatment

, Volume 94, Issue 1, pp 11–16 | Cite as

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

  • Zhenhuan Zhang
  • Hiroko Yamashita
  • Tatsuya Toyama
  • Hiroshi Sugiura
  • Yoshiaki Ando
  • Keiko Mita
  • Maho Hamaguchi
  • Yasuo Hara
  • Shunzo Kobayashi
  • Hirotaka IwaseEmail author


Estrogen is well-established as a mitogenic factor implicated in the tumorigenesis and progression of breast cancer via its binding to the estrogen receptor α (ERα). Recent data indicate that chromatin inactivation mediated by histone deacetylation (HDAC) and DNA methylation is a critical component of ERα silencing in human breast cancer cells. The aim of this study was to determine the expression of the HDAC1 gene in malignant human breast tissue and to correlate our observations with available clinical information. In the present study, the level of expression of HDAC1 mRNA was assessed by LightCycler-based quantitative real-time reverse transcriptase (RT)-PCR analysis in 162 cases of invasive carcinoma of the breast. Associations between HDAC1 mRNA expression and different clinicopathological factors were sought. It was found that HDAC1 mRNA was expressed at significantly higher levels in tumors from patients over 50 years of age and in those tumors without axillary lymph node involvement, that are less than 2 cm, that are of a non-high histological grade, that are HER2 negative and that are ERα/PgR positive. Patients with tumors displaying high levels of HDAC1 mRNA expression tended to have a better prognosis in terms of both disease-free and overall survival. However, univariate and multivariate analysis did not show HDAC1 mRNA expression level to be an independent prognostic factor for either disease-free or overall survival. These results imply that HDAC1 mRNA expression could have potential as an endocrine response marker and may have prognostic implications for breast cancer progression.

Key words

breast cancer estrogen receptor HDAC1 mRNA progesterone receptor prognosis real-time RT-PCR 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Osborne, CK 1998Steroid hormone receptors in breast cancer managementBreast Cancer Res Treat51227238CrossRefPubMedGoogle Scholar
  2. 2.
    Hortobagyi, GN 1998Treatment of breast cancerN Engl J Med339974984CrossRefPubMedGoogle Scholar
  3. 3.
    Weigel, RJ, deConinck, EC 1993Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinomaCancer Res5334723474PubMedGoogle Scholar
  4. 4.
    Cameron, EE, Bachman, KE, Myohanen, S, Herman, JG, Baylin, SB 1999Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerNat Genet21103107CrossRefPubMedGoogle Scholar
  5. 5.
    Yang, X, Ferguson, AT, Nass, SJ, Phillips, DL, Butash, KA, Wang, SM, Herman, JG, Davidson, NE 2000Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibitionCancer Res6068906894PubMedGoogle Scholar
  6. 6.
    Kawai, H, Li, H, Avraham, S, Jiang, S, Avraham, HK 2003Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alphaInt J Cancer107353358CrossRefPubMedGoogle Scholar
  7. 7.
    Macaluso, M, Cinti, C, Russo, G, Russo, A, Giordano, A 2003pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancerOncogene2235113517CrossRefPubMedGoogle Scholar
  8. 8.
    Goldhirsch, A, Wood, WC, Senn, HJ, Glick, JH, Gelber, RD 1995Meeting highlights: international consensus panel on the treatment of primary breast cancerJ Natl Cancer Inst8714411445PubMedGoogle Scholar
  9. 9.
    Elston, CW, Ellis, IO 1991Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-upHistopathology19403410PubMedGoogle Scholar
  10. 10.
    Harada, N, Hatano, O 1998Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cellsBr J Cancer77567572PubMedGoogle Scholar
  11. 11.
    Toyama, T, Iwase, H, Watson, P, Muzik, H, Saettler, E, Magliocco, A, DiFrancesco, L, Forsyth, P, Garkavtsev, I, Kobayashi, S, Riabowol, K 1999Suppression of ING1 expression in sporadic breast cancerOncogene1851875193CrossRefPubMedGoogle Scholar
  12. 12.
    Zhang, Z, Yamashita, H, Toyama, T, Omoto, Y, Sugiura, H, Hara, Y, Wu, X, Kobayashi, S, Iwase, H 2003Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breastBreast Cancer Res5R250R256CrossRefPubMedGoogle Scholar
  13. 13.
    Bieche, I, Laurendeau, I, Tozlu, S, Olivi, M, Vidaud, D, Lidereau, R, Vidaud, M 1999Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assayCancer Res5927592765PubMedGoogle Scholar
  14. 14.
    Kobayashi, S, Ito, Y, Ando, Y, Omoto, Y, Toyama, T, Iwase, H 2000Comparison of five different antibodies in the immunohistochemical assay of estrogen receptor alpha in human breast cancerBreast Cancer7136141PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang, Z, Yamashita, H, Toyama, T, Hara, Y, Omoto, Y, Sugiura, H, Kobayashi, S, Harada, N, Iwase, H 2002Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breastBreast Cancer Res Treat744753CrossRefPubMedGoogle Scholar
  16. 16.
    Harvey, JM, Clark, GM, Osborne, CK, Allred, DC 1999Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancerJ Clin Oncol1714741481PubMedGoogle Scholar
  17. 17.
    Yamashita, H, Nishio, M, Toyama, T, Sugiura, H, Zhang, Z, Kobayashi, S, Iwase, H 2004Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancerBreast Cancer Res6R24R30CrossRefPubMedGoogle Scholar
  18. 18.
    Wolffe, AP 2001Chromatin remodeling: why it is important in cancerOncogene2029882990CrossRefPubMedGoogle Scholar
  19. 19.
    Thiagalingam, S, Cheng, KH, Lee, HJ, Mineva, N, Thiagalingam, A, Ponte, JF 2003Histone deacetylases: unique players in shaping the epigenetic histone codeAnn NY Acad Sci98384100PubMedCrossRefGoogle Scholar
  20. 20.
    Loidl, P 1988Towards an understanding of the biological function of histone acetylationFEBS Lett2279195CrossRefPubMedGoogle Scholar
  21. 21.
    Roth, SY, Denu, JM, Allis, CD 2001Histone acetyltransferasesAnnu Rev Biochem7081120CrossRefPubMedGoogle Scholar
  22. 22.
    Vidal, M, Gaber, RF 1991RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae Mol Cell Biol1163176327PubMedGoogle Scholar
  23. 23.
    Taunton, J, Hassig, CA, Schreiber, SL 1996A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3pScience272408411PubMedGoogle Scholar
  24. 24.
    Ng, HH, Bird, A 2000Histone deacetylases: silencers for hireTrends Biochem Sci25121126CrossRefPubMedGoogle Scholar
  25. 25.
    Ahringer, J 2000NuRD and SIN3 histone deacetylase complexes in developmentTrends Genet16351356CrossRefPubMedGoogle Scholar
  26. 26.
    Glaser, KB, Li, J, Staver, MJ, Wei, RQ, Albert, DH, Davidsen, SK 2003Role of class I and class II histone deacetylases in carcinoma cells using siRNABiochem Biophys Res Commun310529536CrossRefPubMedGoogle Scholar
  27. 27.
    Marks, P, Rifkind, RA, Richon, VM, Breslow, R, Miller, T, Kelly, WK 2001Histone deacetylases and cancer: causes and therapiesNat Rev Cancer1194202CrossRefPubMedGoogle Scholar
  28. 28.
    Choi, JH, Kwon, HJ, Yoon, BI, Kim, JH, Han, SU, Joo, HJ, Kim, DY 2001Expression profile of histone deacetylase 1 in gastric cancer tissuesJpn J Cancer Res9213001304PubMedGoogle Scholar
  29. 29.
    Kim, JH, Choi, YK, Kwon, HJ, Yang, HK, Choi, JH, Kim, DY 2004Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1J Gastroenterol Hepatol19218224CrossRefPubMedGoogle Scholar
  30. 30.
    Toh, Y, Yamamoto, M, Endo, K, Ikeda, Y, Baba, H, Kohnoe, S, Yonemasu, H, Hachitanda, Y, Okamura, T, Sugimachi, K 2003Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinomaOncol Rep10333338PubMedGoogle Scholar
  31. 31.
    Halkidou, K, Gaughan, L, Cook, S, Leung, HY, Neal, DE, Robson, CN 2004Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancerProstate59177189CrossRefPubMedGoogle Scholar
  32. 32.
    Sasaki, H, Moriyama, S, Nakashima, Y, Kobayashi, Y, Kiriyama, M, Fukai, I, Yamakawa, Y, Fujii, Y 2004Histone deacetylase 1 mRNA expression in lung cancerLung Cancer46171178CrossRefPubMedGoogle Scholar
  33. 33.
    Khochbin, S, Verdel, A, Lemercier, C, Seigneurin-Berny, D 2001Functional significance of histone deacetylase diversityCurr Opin Genet Dev11162166CrossRefPubMedGoogle Scholar
  34. 34.
    Ruijter, AJ, Gennip, AH, Caron, HN, Kemp, S, Kuilenburg, AB 2003Histone deacetylases (HDACs): characterization of the classical HDAC familyBiochem J370737749CrossRefPubMedGoogle Scholar
  35. 35.
    Meehan, WJ, Samant, RS, Hopper, JE, Carrozza, MJ, Shevde, LA, Workman, JL, Eckert, KA, Verderame, MF, Welch, DR 2004Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcriptionJ Biol Chem27915621569CrossRefPubMedGoogle Scholar
  36. 36.
    Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE: Release of methyl CpG binding proteins and Histone Deacetylase 1 from the estrogen receptor Alpha (ER) Promoter upon reactivation in ER-negative human breast cancer cells. Mol. Endocrinol., Mar 2005, 10.1210/me.2004–0011Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Zhenhuan Zhang
    • 1
  • Hiroko Yamashita
    • 1
  • Tatsuya Toyama
    • 1
  • Hiroshi Sugiura
    • 1
  • Yoshiaki Ando
    • 1
  • Keiko Mita
    • 1
  • Maho Hamaguchi
    • 1
  • Yasuo Hara
    • 1
  • Shunzo Kobayashi
    • 2
  • Hirotaka Iwase
    • 1
    Email author
  1. 1.Department of Breast and Endocrine Surgery, Medical SchoolNagoya City University HospitalMizuho-kuJapan
  2. 2.Department of SurgeryJosai Municipal Hospital of Nagoyaakamura-kuJapan

Personalised recommendations